PP405 0.05% Topical Gel for alopecia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 30 Oct 2026: Trial registered, NCT07907783

The trials

NCT07907783: Phase 2 Efficacy and Safety of PP405 in Adult Females With Androgenetic Alopecia

State
Under way
Phase
Phase 2
People
200 planned
Started
10 Nov 2026
Primary completion
Sep 2027
Arms
PP405 0.05% Topical Gel
Results
None posted
  1. 30 Oct 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.